Gainers
- PureTech Health PRTC stock rose 30.9% to $25.0 during Monday's pre-market session. The market value of their outstanding shares is at $598.5 million.
- Telix Pharmaceuticals TLX shares increased by 21.88% to $22.0. The market value of their outstanding shares is at $7.3 billion.
- Microbot Medical MBOT shares rose 18.43% to $3.02. The market value of their outstanding shares is at $84.6 million.
- Nektar Therapeutics NKTR shares rose 16.84% to $0.79. The market value of their outstanding shares is at $145.7 million.
- Cutera CUTR shares rose 12.74% to $0.49. The company's market cap stands at $9.9 million.
- Solid Biosciences SLDB stock increased by 12.5% to $3.24. The company's market cap stands at $129.4 million.
Losers
- Pliant Therapeutics PLRX shares declined by 57.6% to $3.3 during Monday's pre-market session. The company's market cap stands at $200.8 million.
- Precipio PRPO stock declined by 24.87% to $5.0. The market value of their outstanding shares is at $7.4 million.
- Replimune Group REPL stock fell 19.59% to $11.21. The company's market cap stands at $862.6 million.
- Conduit Pharmaceuticals CDT shares decreased by 17.55% to $2.35. The company's market cap stands at $3.6 million.
- Cyclo Therapeutics CYTH shares fell 15.13% to $1.01. The market value of their outstanding shares is at $33.0 million.
- OptiNose OPTN stock declined by 12.05% to $5.11. The market value of their outstanding shares is at $51.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
CUTRCutera Inc
$0.494612.7%
CYTHCyclo Therapeutics Inc
$1.03-13.4%
MBOTMicrobot Medical Inc
$3.0118.0%
NKTRNektar Therapeutics
$0.6666-1.39%
OPTNOptiNose Inc
$5.10-12.2%
PLRXPliant Therapeutics Inc
$3.25-58.3%
PRPOPrecipio Inc
$5.00-27.9%
PRTCPureTech Health PLC
$27.0044.3%
REPLReplimune Group Inc
$11.21-19.6%
SLDBSolid Biosciences Inc
$3.3817.4%
TLXTelix Pharmaceuticals Ltd
$22.0021.9%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in